Amarin Corp Plc market cap AMRN
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $249M
- Highest close in our data
- $8.7B
- Dec 2019
Amarin Corp Plc is worth $249M at the close on Oct 23, 2026, at $11.79 a share.
That is down 39% over the last year and down 87% over five years.
Its highest close in our data was $8.7B in Dec 2019.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $249M | $239.1M | $343.3M | −15% |
| 2025 | $294M | $166.7M | $407.9M | +60% |
| 2024 | $184.3M | $184.3M | $538.9M | −48% |
| 2023 | $355.2M | $281.5M | $844M | −27% |
| 2022 | $488.6M | $439.5M | $1.4B | −63% |
| 2021 | $1.3B | $1.3B | $3.3B | −30% |
| 2020 | $1.9B | $1.5B | $7.5B | −75% |
| 2019 | $7.7B | $4B | $8.7B | +92% |
| 2018 | $4B | $772.1M | $7B | +271% |
| 2017 | $1.1B | $789.6M | $1.1B | +31% |
| 2016 | $831.5M | $758.6M | $923.2M | n/a |
| 2015 | n/m not a meaningful number | |||
| 2014 | n/m not a meaningful number | |||
| 2013 | $223.1M | $223.1M | $1.2B | −79% |
| 2012 | $1B | $914.6M | $2.1B | +3% |
| 2011 | $1B | $860.4M | $1.7B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Amarin Corp Plc's size, closest first, today.
| Company | Market cap |
|---|---|
| AMRNAmarin Corp Plc | $249M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| Peer median | $570.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Amarin Corp Plc
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.